First Citizens Bank & Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

First Citizens Bank & Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.78M	Sell	7,373 -2,238	-23%	-$490K	0.03%	239
2026 Q1	$1.82M	Sell	9,611 -502	-5%	-$87.7K	0.04%	225
2025 Q4	$1.72M	Buy	10,113 +347	+4%	+$53.2K	0.04%	215
2025 Q3	$1.29M	Buy	9,766 +340	+4%	+$40.8K	0.03%	256
2025 Q2	$1M	Buy	9,426 +6,865	+268%	+$746K	0.02%	282
2025 Q1	$318K	Buy	+2,561	New	+$334K	0.01%	374
2013 Q4	–	Sell	-4,885	Closed	-$449K	–	568
2013 Q3	$449K	Buy	+4,885	New	+$394K	0.02%	755

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

First Citizens Bank & Trust's JAZZ Position: Q2 2026 in Review

First Citizens Bank & Trust reduced its Jazz Pharmaceuticals (JAZZ) stake by 23% in Q2 2026, selling an estimated $490K and leaving 7,373 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #239.

First Citizens Bank & Trust first reported a position in JAZZ in Q3 2013 and has held it in 7 quarters since. The position peaked at $1.82M in Q1 2026. 86 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

First Citizens Bank & Trust held 7,373 shares of Jazz Pharmaceuticals worth $1.78M as of Q2 2026.
First Citizens Bank & Trust sold 2,238 Jazz Pharmaceuticals shares in Q2 2026, an estimated $490K.
Jazz Pharmaceuticals made up 0.03% of First Citizens Bank & Trust's portfolio in Q2 2026, its #239 holding.
First Citizens Bank & Trust first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 7 quarters since.
First Citizens Bank & Trust's Jazz Pharmaceuticals position peaked at $1.82M in Q1 2026.
86 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.